Skip to main content
. Author manuscript; available in PMC: 2011 Oct 1.
Published in final edited form as: Arterioscler Thromb Vasc Biol. 2010 Oct;30(10):2014–2021. doi: 10.1161/ATVBAHA.110.210237

Figure 4.

Figure 4

(A) Relative expression of ABCA1 and ABCG1 mRNAs in J774 cells treated for 20 hr with either 10 μM LPC or vehicle (n=6). (B) Relative expression of ABCA1 and ABCG1 mRNAs in J774 cells treated with either 10 μM arachidonic acid (AA) or vehicle for 8 hr (n=4). **p < 0.01 compared to untreated cells. (C) [3H]-AA release during 6 h was quantified and expressed as the percent of total cellular [3H]-AA. (D) [3H]-AA release during 6 h by untreated J774 cells (UT) and J774 cells treated with 0.1 μg/ml GX sPLA2 (+GX) expressed as the percent of total cellular [3H]-AA. ***, p < 0.001. (E) PGE2 in conditioned media of J774-C and J774-GX cells treated for 6 hr with 100 ng/ml LPS in the presence or absence of 1 μM indomethacin (indometh). (F) Relative expression of ABCA1 and ABCG1 mRNAs in J774-C and J774-GX cells incubated with either 1 μM indomethacin or vehicle for 6 hr. Data shown are representative of at least 2 independent experiments. Data that are not significantly different (p ≥ 0.05) are indicated with the same letter.